Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age
NEJM Evidence · 24.10.2023 · 2 (11)
DOI: 10.1056/evidoa2300145 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift NEJM Evidence, erschienen am 24.10.2023. Verfasst von George Du Toit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guy's and St. Thomas' National Health Service Foundation Trust and Kings College, London. Hauptthemen laut MEDLINE: Peanut Hypersensitivity. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 23 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND: Peanut allergy is a common childhood allergy, and the only approved treatment for children 4 to 17 years of age is peanut allergen powder-dnfp (PTAH) oral immunotherapy. METHODS: For this phase 3, randomized, double-blind, placebo-controlled trial, we enrolled peanut-allergic children 1 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Guy's and St. Thomas' National Health Service Foundation Trust and Kings College, London.
- Aimmune Therapeutics, Nestlé Health Science, Brisbane, CA.
- Aimmune Therapeutics, Nestlé Health Science, London.
- University of Arkansas for Medical Sciences and Arkansas Children's Hospital, Little Rock.
- Emory University School of Medicine, Atlanta.
Zitieren
APA
Du Toit, G., Brown, K. R., Vereda, A., Irani, A. M., Tilles, S., Ratnayake, A., Jones, S. M., & Vickery, B. P. (2023). Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age. NEJM Evidence, 2(11). https://doi.org/10.1056/evidoa2300145
Vancouver
Du Toit G, Brown KR, Vereda A, Irani AM, Tilles S, Ratnayake A, et al. Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age. NEJM Evidence. 2023;2(11). doi:10.1056/evidoa2300145
BibTeX
@article{DuToit2023,
author = {Du Toit, George and Brown, Kari R and Vereda, Andrea and Irani, Anne-Marie and Tilles, Stephen and Ratnayake, Anoshie and Jones, Stacie M and Vickery, Brian P},
title = {Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age},
journal = {NEJM Evidence},
year = {2023},
volume = {2},
number = {11},
doi = {10.1056/evidoa2300145}
}
EUVIMED